Heterogeneity of HER2 Expression in Circulating Tumor Cells of Patients with Breast Cancer Brain Metastases and Impact on Brain Disease Control

SIMPLE SUMMARY: Results from a previous study suggested that the number of circulating tumor cells (CTC) might have a role as a biomarker of early distant brain failure in patients with breast cancer brain metastases (BCBM). However, it remains largely underexplored whether heterogeneous HER2 expres...

Descripción completa

Detalles Bibliográficos
Autores principales: de Castro, Douglas Guedes, Pellizzon, Antônio Cássio Assis, Braun, Alexcia Camila, Chen, Michael Jenwei, Silva, Maria Letícia Gobo, Fogaroli, Ricardo Cesar, Gondim, Guilherme Rocha Melo, Ramos, Henderson, Neto, Elson Santos, Abrahão, Carolina Humeres, Yu, Liao Shin, Abdallah, Emne Ali, Calsavara, Vinicius Fernando, Chinen, Ludmilla Thomé Domingos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264951/
https://www.ncbi.nlm.nih.gov/pubmed/35804873
http://dx.doi.org/10.3390/cancers14133101

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264951/
https://www.ncbi.nlm.nih.gov/pubmed/35804873
http://dx.doi.org/10.3390/cancers14133101

Ejemplares similares